SCHEMBL5128482

SCHEMBL5128482

COC(=O)CN(c1csc(-c2cccc(N)c2)c1C)S(=O)(=O)NC(=O)OC(C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
CA12 O43570 3/20 0.32
CA14 Q9ULX7 3/20 0.32
CA1 P00915 2/20 0.32
CA7 P43166 2/20 0.32
CA2 P00918 1/20 0.32
HDAC3 O15379 2/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC10 Q969S8 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
NCOR2 Q9Y618 1/20 0.32
MCOLN3 Q8TDD5 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
GRM6 O15303 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.31
RAB9A P51151 1/20 0.31
HSD17B10 Q99714 1/20 0.31
PTPN1 P18031 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5123264 0.89 CA12 (0.39) ALDH1A1CA12CA14CA1CA7
SCHEMBL5117806 0.86 ALOX5 (0.42) ALDH1A1SMN1; SMN2MAPTRAB9A
SCHEMBL5117004 0.83 PTPN1 (0.39) HDAC3HDAC1HDAC2HDAC10PTPN1
SCHEMBL5116798 0.81 PTPN1 (0.42) PTPN1
SCHEMBL5127766 0.80 CA12 (0.39) ALDH1A1CA12CA14CA1CA7
SCHEMBL5123712 0.79 CA12 (0.39) ALDH1A1CA12CA14CA1CA7
SCHEMBL5120240 0.75 CA12 (0.40) ALDH1A1CA12CA14CA1CA7
SCHEMBL5130066 0.75 PTPN1 (0.38) ALDH1A1MAPTHSD17B10PTPN1
SCHEMBL5118668 0.71 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2KDM4EMAPTRAB9A
SCHEMBL1731086 0.69 GAA (0.46) ALDH1A1CA12CA14CA1CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004325-A1 PTP1B inhibitors WYETH (US) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004325-A1 PTP1B inhibitors PTPA, PTPRJ, PTPRR ALDH1A1 1266/4885CA12 4823/4885CA14 4854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.